{
    "clinical_study": {
        "@rank": "9782", 
        "arm_group": [
            {
                "arm_group_label": "pregabalin", 
                "arm_group_type": "Active Comparator", 
                "description": "perioperative pregabalin starting the evening before surgery, and for five days postoperatively"
            }, 
            {
                "arm_group_label": "pregabalin and continuous wound infusion", 
                "arm_group_type": "Active Comparator", 
                "description": "Pregabalin as previous group and continuous infusion of ropivacaine 0.2% via a wound catheter"
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo drug and normal saline infusion"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess the efficacy of pregabalin or pregabalin and\n      continuous wound infusion versus placebo for analgesia following thoracotomy"
        }, 
        "brief_title": "Perioperative Pregabalin and Continuous Wound Infusion for Pain Control Following Thoracotomy", 
        "completion_date": {
            "#text": "May 2012", 
            "@type": "Actual"
        }, 
        "condition": "Post-thoracotomy Pain", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients scheduled for a thoracotomy,\n\n        Exclusion Criteria:\n\n          -  age >70 years\n\n          -  BMI > 30\n\n          -  preoperative Hb < 10 mg/dL\n\n          -  preexistent chronic pain\n\n          -  neurologic disease\n\n          -  chronic assumption of alcohol\n\n          -  treatment with analgesics, anxiolytics, sedatives, antidepressants, or calcium\n             channel inhibitors"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "45", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 9, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01726205", 
            "org_study_id": "PRGCWI1"
        }, 
        "intervention": [
            {
                "arm_group_label": "pregabalin", 
                "intervention_name": "Pregabalin and normal saline infusion, PRG", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "pregabalin and continuous wound infusion", 
                "intervention_name": "Pregabalin and ropivacaine 02% infusion", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "placebo", 
                "intervention_name": "Placebo drug, normal saline infusion", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ropivacaine", 
                "Pregabalin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 9, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Athens", 
                    "country": "Greece"
                }, 
                "name": "Attikon Hospital"
            }
        }, 
        "location_countries": {
            "country": "Greece"
        }, 
        "number_of_arms": "3", 
        "other_outcome": {
            "measure": "side effects, pain at 1 and 3 months, incidence of neuropathic pain", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "overall_official": [
            {
                "affiliation": "Attikon Hospital", 
                "last_name": "Tatiana Sidiropoulou", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Attikon Hospital", 
                "last_name": "Eyaggelos Giavasopoulos", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Greece: Ethics Committee", 
                "Greece: Ministry of Health and Welfare"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Pain control", 
            "safety_issue": "No", 
            "time_frame": "5 days postoperatively"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01726205"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Attikon Hospital", 
            "investigator_full_name": "Sidiropoulou Tatiana", 
            "investigator_title": "Lecturer in Anesthesiology, University of Athens", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "morphine consumption", 
            "safety_issue": "No", 
            "time_frame": "3 days postoperatively"
        }, 
        "source": "Attikon Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Attikon Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2008", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}